Sensei Biotherapeutics announces 1-for-20 reverse stock split effective June 16

Sensei Biotherapeutics, Inc.

Reverse stock split at 1-for-20 ratio effective 5:00 p.m. ET on June 16, 2025.
Authorized shares reduced from 250,000,000 to 12,500,000; par value unchanged.
No fractional shares issued; stockholders receive cash payment in lieu.
Common stock trades on split-adjusted basis on Nasdaq Capital Market starting June 17, 2025.
Outstanding stock options, RSUs, and warrants proportionately adjusted.

item 5.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.